OptimizeRx (OPRX) Other Operating Expenses (2010 - 2026)

OptimizeRx has disclosed Other Operating Expenses across 17 years of filings, most recently posting $11.4 million for Q2 2026.

• In Q2 2026, Other Operating Expenses fell 29.92% year-over-year to $11.4 million; the TTM figure through Jun 2026 stood at $39.2 million (down 32.07% YoY), while the FY2025 annual figure was $11.6 million, down 50.14% from the prior year.
• Other Operating Expenses came in at $11.4 million for Q2 2026 at OptimizeRx, up from $11.2 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $28.7 million in Q4 2023 to a low of $464000.0 in Q1 2023.
• Average Other Operating Expenses over 5 years is $8.2 million, with a median of $4.8 million recorded in 2024.
• Year-over-year, Other Operating Expenses slumped 90.83% in 2022 and soared 1738.12% in 2024.
• Over 5 years, Other Operating Expenses stood at $16.2 million in 2022, then soared by 77.41% to $28.7 million in 2023, then slumped by 36.03% to $18.4 million in 2024, then slipped by 15.54% to $15.5 million in 2025, then decreased by 26.84% to $11.4 million in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $11.4 million in Q2 2026, $11.2 million in Q1 2026, and $15.5 million in Q4 2025.